Two research teams reported detecting prions using different versions of the same assay, and one said it could detect the proteins before the onset of symptoms.
A proteomic analysis of pancreatic ductal adenocarcinoma tumor and stromal samples led to a stromal protein that appears to coincide with tumor aggressiveness.
The initiative, launched last year by Quest and the French National Institute of Health and Medical Research, has reclassified 375 variants of unknown significance so far.
Ranomics is building a business around providing functional data on variants of unknown significance, starting with BRCA1 mutations.
Using data from more than 800 colorectal cancer samples, researchers concluded that features in the microenvironment may protect against metastasis.
A French team sequenced and compared Streptococcus agalactiae isolates from 19 mothers and their infected infants.
The field needs a database that can help inform variant classifications reported to patients, but Quest finds most publicly available resources aren't robust enough for this purpose.
In joining forces to support BRCAShare, Quest and LabCorp are taking on Myriad Genetics, which maintains a proprietary database with more than 1 million test results.
An INSERM-led team has uncovered new hepatocellular carcinoma mutational signatures that reflect exposure to certain disease risk factors.
The technology compensates for genomic DNA amplified in qPCR gene expression measurements.
A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.
Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.
In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.
A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.